NRXP NRX Pharmaceuticals, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: $94.8M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $58.0K | $304.2K |
| 2022-Q3 | $0 | $791.9K |
| 2022-Q4 | $633.7K | $654.0K |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $128.5K | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $46.8K | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$867.0K13 buy days
Sold$1.8M10 sell days
Net insider flow-$883.1Knet selling · 5 years
Latest trade2024-12-17Javitt Jonathan C
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2024-12-17 | Buy | Javitt Jonathan C | Chair | 40,000 | $1.17 | $46.8K | 1 |
| 2023-08-30 | Buy | Hurvitz Chaim | Director | 70,000 | $0.29 | $20.3K | 1 |
| 2023-08-30 | Buy | Gorovitz Aaron | Director | 35,000 | $0.32 | $11.2K | 1 |
| 2023-08-23 | Buy | Javitt Jonathan C | Other C-suite | 100,000 | $0.33 | $33.0K | 1 |
| 2023-08-22 | Buy | Javitt Jonathan C | Other C-suite | 200,000 | $0.32 | $64.0K | 1 |
| 2022-12-16 | Buy | Willard Stephen H | CEO | 50,000 | $1.17 | $58.5K | 1 |
| 2022-12-16 | Buy | VAN VOORHEES SETH | CFO | 30,000 | $1.10 | $33.0K | 1 |
| 2022-12-07 | Sell | Javitt Jonathan C | Director | 400,000 | $1.00 | $400.0K | 1 |
| 2022-11-30 | Sell | Javitt Daniel C. | 10% owner | 8,441 | $1.50 | $12.7K | 1 |
| 2022-11-29 | Sell | Javitt Daniel C. | 10% owner | 13,730 | $1.50 | $20.6K | 1 |
| 2022-11-28 | Buy | Flynn Patrick John | Director | 6,750 | $1.25 | $8.4K | 3 |
| 2022-11-25 | Buy | VAN VOORHEES SETH | CFO | 16,937 | $1.11 | $18.9K | 4 |
| 2022-11-18 | Buy | Hurvitz Chaim | Director | 40,408 | $1.10 | $44.4K | 1 |
| 2022-11-17 | Buy | Hurvitz Chaim | Director | 171,780 | $1.08 | $185.5K | 1 |
| 2022-11-17 | Sell | Javitt Daniel C. | 10% owner | 33,018 | $1.05 | $34.7K | 1 |
| 2022-11-16 | Buy | Hurvitz Chaim | Director | 287,812 | $0.99 | $284.9K | 1 |
| 2022-11-16 | Sell | Javitt Daniel C. | 10% owner | 133,719 | $1.02 | $136.4K | 1 |
| 2022-11-11 | Sell | Javitt Daniel C. | 10% owner | 49,200 | $1.01 | $49.7K | 1 |
| 2022-07-29 | Sell | Javitt Daniel C. | 10% owner | 784,063 | $1.01 | $791.9K | 1 |
| 2022-06-07 | Sell | Javitt Daniel C. | 10% owner | 86,459 | $0.65 | $56.2K | 1 |
| 2022-06-06 | Sell | Javitt Daniel C. | 10% owner | 115,657 | $0.67 | $77.5K | 1 |
| 2022-06-03 | Sell | Javitt Daniel C. | 10% owner | 243,596 | $0.70 | $170.5K | 1 |
| 2022-06-01 | Buy | Javitt Jonathan C | Other C-suite | 100,000 | $0.58 | $58.0K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Javitt Daniel C. | 10% owner | $0 | $1.4M | 2022-11-30 |
| Javitt Jonathan C | Chair | $201.8K | $400.0K | 2024-12-17 |
| Hurvitz Chaim | Director | $535.2K | $0 | 2023-08-30 |
| Willard Stephen H | CEO | $58.5K | $0 | 2022-12-16 |
| VAN VOORHEES SETH | CFO | $51.9K | $0 | 2022-12-16 |
| Gorovitz Aaron | Director | $11.2K | $0 | 2023-08-30 |
| Flynn Patrick John | Director | $8.4K | $0 | 2022-11-28 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2023-08-22 → 2023-08-30 | 3 | $128.5K | 39 | +16.0% (+11.4% raw) | +34.1% (+35.4% raw) | +67.9% (+79.4% raw) | closed |
| 2022-11-16 → 2022-12-16 | 4 | $633.7K | 57 | -12.7% (-16.2% raw) | -45.0% (-40.8% raw) | -41.2% (-43.8% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.